Table 2 Intra-operative and post-operative characteristics
N | Percent | Median | Range | |
|---|---|---|---|---|
All patients (HIPEC) | 91 | 100 | ||
Primary tumor | ||||
Colon | 81 | 89 | ||
Rectum | 10 | 11 | ||
CC score | ||||
0 | 90 | 98.9 | ||
1 | 1 | 1.1 | ||
2 | 0 | 0 | ||
PCI | 6 | 0–23 | ||
HIPEC oxaliplatin dose | ||||
300 mg/m2 | 12 | 13.2 | ||
460 mg/m2 | 79 | 86.8 | ||
Organ resected | 2 | 0–6 | ||
Anastomosis | 1 | 0–3 | ||
Operative time (min) | 330 | 105–690 | ||
Open vs close abdomen | ||||
Open | 29 | 32 | ||
Close | 62 | 68 | ||
IV Chemotherapy | ||||
Yes (5-FU + LV) | 68 | 75 | ||
No | 23 | 25 | ||
Blood loss (ml) | 375 | 100–5000 | ||
Blood transfusion | 4 | 4.4 | ||
Admission to ICU | 76 | 83.5 | ||
Parenteral nutrition | 68 | 74.7 | ||
Length of stay (days) | 16 | 6–67 | ||
Post-operative complications | ||||
None | 43 | 47.2 | ||
Grade 1 | 26 | 28.6 | ||
Grade 2 | 11 | 12.1 | ||
Grade 3 | 5 | 5.5 | ||
Grade 4 | 5 | 5.5 | ||
Grade 5 | 1 | 1.1 | ||
Follow-up (months) | 24 | 0–137 |